Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cimetidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 known ✓ | P25021 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | GLA | P06280 | 1/20 | 0.72 |
| ▸ | ATP4A | P20648 | 1/20 | 0.72 |
| ▸ | APEX1 | P27695 | 1/20 | 0.72 |
| ▸ | PDE4A | P27815 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | ATP4B | P51164 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.72 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.72 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10412368 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL11353266 | 0.89 | CYP3A4 (0.81) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL11084201 | 0.89 | HRH2 (0.57) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL9279930 | 0.89 | HRH2 (0.57) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL11001853 | 0.89 | HRH2 (0.57) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL11075509 | 0.89 | HRH2 (0.57) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL11001852 | 0.89 | HRH2 (0.57) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL11366119 | 0.87 | CYP3A4 (0.74) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL7653936 | 0.87 | CYP3A4 (0.67) | CYP3A4CYP2D6LMNATSHRHRH2 | |
| SCHEMBL10413112 | 0.87 | CYP3A4 (0.67) | CYP3A4CYP2D6LMNATSHRHRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103536570-A | Cimetidine composition lyophilized oral-disintegration tablets | HAINAN WEIKANG PHARM QIANSHAN | 2014-01-29 | — | — | CN | claimed |
| US-5466696-A | Mixtures for treatment of alzheimer's disease | WARNER LAMBERT COMPANY (US) | 1995-11-14 | — | — | US | claimed |
| EP-0161501-A1 | Anti-ulcer means for the treatment of abscesses | T P O "PHARMACHIM" (BG) | 1985-11-21 | — | — | EP | claimed |
| US-4200761-A | Process for preparing N-cyano-N'methyl-N\"-{2-[(4-methyl-5-imidazolyl)-methylthio]-ethyl} guanidine | LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) | 1980-04-29 | — | — | US | claimed |
| US-4024271-A | INHIBITORS OF HISTAMINE ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | claimed |
| US-4000302-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-12-28 | — | — | US | claimed |
| US-3950333-A | HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | claimed |
| JP-58092664-A | — | — | None | — | — | JP | disclosed |
| JP-60067467-A | — | — | None | — | — | JP | disclosed |
| JP-59033283-A | — | — | None | — | — | JP | disclosed |
| CN-110950815-B | Green synthesis method of anticoccidial veterinary drug cimetiril | 山东国邦药业有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-110950815-A | Green synthesis method of anticoccidial veterinary drug cimetiril | 山东国邦药业有限公司 | 2020-04-03 | — | — | CN | disclosed |
| CN-107361216-A | A kind of complex group agent and its application for being used to improve dry milk phase milk cow body condition | 新疆农业大学 | 2017-11-21 | — | — | CN | disclosed |
| US-4070475-A | THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1978-01-24 | — | — | US | disclosed |
| US-4056620-A | INHIBITION OF HISTAMINE H-2 RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-11-01 | — | — | US | disclosed |
| US-4024271-A | INHIBITORS OF HISTAMINE ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | disclosed |
| US-4022797-A | PHARMACEUTICALS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-10 | — | — | US | disclosed |
| US-4000302-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-12-28 | — | — | US | disclosed |
| US-4000302-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-12-28 | — | — | US | disclosed |
| US-3950333-A | HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |